USA Today: Conflicts of interest bedevil psychiatric drug research
Psychiatry’s leadership is scrambling and fumbling in its effort to explain why it’s collusion with industry for pay is okay.
Antidepressants-Paxil, Prozac, Zoloft Increase Risk of Breast Cancer
Inexplicably, the FDA has dragged its feet about adding a warning label to both tamoxefin and the antidepressants, Paxil, Prozac and Zoloft–despitethe unanimous recommendation of its own advisory panel in 2006.
Rx for Antipsychotc Drugs for Children Begin To Decelerate_WSJ
This is a result of public awareness–thanks to information uncovered during litigation, by Sen. Charles Grassley’s investigative team, by whistleblowers, and the press!
Has the Obama administration already cowered to the demands of Big Pharma?
Forbes Magazine reports "How one company turned a rejection into a thumbs up, and what it could mean for the drug industry as a whole."
Title: FDA Approves Antipsychotic With Long History of Failure
The FDA has just approved the anitpsychotic drug, Fanapt (iloperidone) for adults with schizophrenia.
The drug, iloperidone, has a long history of failure. http://en.wikipedia.org/wiki/Iloperidone :
QuaterWatch: 1,000 + deaths –>Digoxin / Suicide/ Violence –>Chantix
The latest QuarterWatch report (May 7, 2009) by the Institute for Safe Medication Practices (ISMP) found the following disturbing trends during the third Quarter of 2008:
FDA-US Justice Dept. Withdraw Amicus Brief in Colacicco v. Apotex Inc,
“Every failure-to-warn case against a drug company has been affected by Wyeth”
Senator Grassley Might Leave Finance Committee: A Break For Pharma?
The Hill , a newspaper covering congressional news, reports: "Sen. Chuck Grassley (Iowa) is considering leaving his powerful post as senior Republican on the Finance Committee so that he can become the highest-ranking Republican on the Judiciary panel. To avoid a dramatic shake-up, Grassley is hoping to strike a deal…
Does the FDA have the authority to trump the Declaration of Helsinki?
The FDA is sliding rapidly down the slippery slope, abandoning widely accepted, international ethical research standards articulated in the internationally accepted, Declaration of Helsinki–to facilitate commercial medical experiments.
AHRP Letter to Harvard Re: Dr. Biederman’s Research
AHRP proposes a multi-disciplinary team of independent scientists to review ALL of Dr. Joseph Biederman’s publications and supporting documents, including: research protocols, consent forms, and the original (of course, anonymized) data sets with associated code books for all pediatric studies.
Culling the $$$ Evidence: National Alliance for Mental Illness
Grassley’s team has asked NAMI to disclose the specifics of its funding so that people with mental illness and their families, as well as the public and healthcare officials, can see for themselves how conflicted this advocacy group is.
Is the FDA Bipolar or Complicit in Legitimizing IIlegal Marketing?
The FDA expanded approval process for toxic drugs is unaffected by evidence uncovered by the US Justice Department showing the studies to be flawed, if not fraudulent.